SENSITIVITY OF DRUG-RESISTANT B-CELL LINES FROM AIDS-RELATED NON-HODGKINS-LYMPHOMA TO NEWLY SYNTHESIZED PODOPHYLLOTOXIN DERIVATIVES AND AZA-ALKYLLYSOPHOSPHOLIPIDS - ENHANCED SENSITIZATION BY PRETREATMENT WITH INTERFERON-GAMMA

Citation
A. Demidem et al., SENSITIVITY OF DRUG-RESISTANT B-CELL LINES FROM AIDS-RELATED NON-HODGKINS-LYMPHOMA TO NEWLY SYNTHESIZED PODOPHYLLOTOXIN DERIVATIVES AND AZA-ALKYLLYSOPHOSPHOLIPIDS - ENHANCED SENSITIZATION BY PRETREATMENT WITH INTERFERON-GAMMA, International journal of oncology, 4(6), 1994, pp. 1203-1209
Citations number
31
Categorie Soggetti
Oncology
ISSN journal
10196439
Volume
4
Issue
6
Year of publication
1994
Pages
1203 - 1209
Database
ISI
SICI code
1019-6439(1994)4:6<1203:SODBLF>2.0.ZU;2-Q
Abstract
Non-Hodgkin's lymphoma B cells (NHL-B) often become refractory to conv entional chemotherapeutic drugs. The present study investigated the se nsitivity of three AIDS-derived NHL-B cell lines to newly synthesized azaalkyllysophospholipids (AALP) and podophyllotoxin derivatives. All three cell lines were sensitive to 5 AALP derivatives and toxicity was detectable at 24 h of culture and was increased at 48 and 72 h of inc ubation. Toxicity was concentration-dependent and die extent of cytoto xicity varied slightly from one cell line to another. These cell lines were less sensitive to the podophyllotoxin derivatives VP-16, BDPTN a nd BEPT than to die AALP. This was shown by the extent of cytotoxicity calculated on a molar basis and by the delayed kinetics of lysis. Pre treatment of the tumor cells with IFN-gamma stimulated cell proliferat ion. IFN-gamma treated tumor cells were also tested for their sensitiv ity to the various cytotoxic agents. In all cases, the sensitivity of the IFN-gamma pretreated cell lines to the podophyllotoxin derivatives and AALP was significantly enhanced. These findings demonstrate that drug resistant NHL-B cells are sensitive to a new family of AALP and p odophyllotoxin derivatives. Further, the sensitivity of the tumor cell s was enhanced by treatment with IFN-gamma. The potential clinical use of these new cytotoxic agents to overcome resistance of AIDS-related cell lymphomas is discussed.